Six weeks of persistent atrial fibrillation in an equine model resulted in increased fibroblast accumulation in several cardiac regions and abolished the rate-dependent slowing of conduction velocity.
Does persistent atrial fibrillation alter conduction velocity and fibroblast accumulation in an equine model?
Persistent atrial fibrillation in an equine model leads to increased fibroblast accumulation and altered conduction velocity, suggesting fibroblasts as a potential therapeutic target for AF structural remodeling.
p-value: p=<0.05
Fibroblasts maintain the extracellular matrix homeostasis and may couple to cardiomyocytes through gap junctions and thereby increase the susceptibility to slow conduction and cardiac arrhythmias, such as atrial fibrillation (AF). In this study, we used an equine model of persistent AF to characterize structural changes and the role of fibroblasts in the development of an arrhythmogenic substrate for AF. Eleven horses were subjected to atrial tachypacing until self-sustained AF developed and were kept in AF for six weeks. Horses in sinus rhythm (SR) served as control. In terminal open-chest experiments conduction velocity (CV) was measured. Tissue was harvested and stained from selected sites. Automated image analysis was performed to assess fibrosis, fibroblasts, capillaries and various cardiomyocyte characteristics. Horses in SR showed a rate-dependent slowing of CV, while in horses with persistent AF this rate-dependency was completely abolished (CV•basic cycle length relation p = 0.0295). Overall and interstitial amounts of fibrosis were unchanged, but an increased fibroblast count was found in left atrial appendage, Bachmann's bundle, intraatrial septum and pulmonary veins (p < 0.05 for all) in horses with persistent AF. The percentage of α-SMA expressing fibroblasts remained the same between the groups. Persistent AF resulted in fibroblast accumulation in several regions, particularly in the left atrial appendage. The increased number of fibroblasts could be a mediator of altered electrophysiology during AF. Targeting the fibroblast proliferation and differentiation could potentially serve as a novel therapeutic target slowing down the structural remodeling associated with AF.
Saljic et al. (Tue,) conducted a other in Persistent atrial fibrillation (n=26). Atrial tachypacing-induced persistent atrial fibrillation vs. Sinus rhythm was evaluated on Fibroblast accumulation and conduction velocity (p=<0.05). Six weeks of persistent atrial fibrillation in an equine model resulted in increased fibroblast accumulation in several cardiac regions and abolished the rate-dependent slowing of conduction velocity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: